Remove 2013 Remove Clinical Trials Remove Patients
article thumbnail

Realm of Caring Appoints Research Director to Oversee Groundbreaking Cannabis Data Registry and Medical Studies

Cannabis Law Report

This study represents a refreshing collaboration of scientists, clinicians, patients and advocates. It is our hope that this study may embolden clinicians and patients to effectively partner in considering these treatments.”. plan to conduct a controlled clinical trial to further understand the effects of CBD in epilepsy treatment.

Data 81
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. 01.015 of the FDR before providing the new drug to a patient. Timeline of Medicinal Legalization in Canada. Pursuant to subsection C.08.010(1)

Therapy 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Science Behind Charlotte’s Web: How CBD Oil Works for Seizure Disorders

LifeCannMD

#image_title By Dr. Fernando Fandio-Sende, LifeCannMD A Little Girl Who Changed Everything I’ll never forget watching that CNN documentary back in 2013. Here’s something that blows most of my patients’ minds: your body actually has built-in receptors for cannabis compounds. Can you even imagine?

CBD 52
article thumbnail

Canada: First patient in Quebec gets approval for magic mushroom therapy

Cannabis Law Report

Andrew Bui-Nguyen, of the Mindspace by Numinus clinic, said in a recent interview. Bui-Nguyen said his clinic received Health Canada’s approval on May 5 to care for a patient who had undergone several unsuccessful treatments for depression. The patient has a lot of work to do. ” Health Canada on Jan.

Therapy 52
article thumbnail

Press Release: Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2

Cannabis Law Report

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

article thumbnail

Swiss Plan To Let 5,000 Citizens Use Cannabis In Major Medical Trial

Cannabis Law Report

Switzerland’s government will allow 5,000 citizens to use cannabis legally, as part of a country-wide clinical trial. Those who sign up to the trial would receive a small amount of cannabis each month, to smoke or eat. In 2013, Switzerland decriminalized possession of small amounts of cannabis, 10 grammes or less.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA. Rick Doblin, Ph.D.,